Ellsworth Advisors, LLC’s Bristol-Myers Squibb Co Position
Does Ellsworth Advisors, LLC own Bristol-Myers Squibb Co (BMY)? Yes — 125.5K shares worth $7M (+1.21% of its 13F portfolio) as of Q2 2026, up from 121.7K shares the prior filed quarter.
Position Value
$7M
Q2 2026
Shares
125.5K
% of Portfolio
+1.21%
Quarters Held
14
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 125.5K | $7M | +1.21% |
| Q1 2026 | 121.7K | $7M | +1.39% |
| Q4 2025 | 115.9K | $7M | +1.30% |
| Q3 2025 | 106.0K | $5M | +0.99% |
| Q2 2025 | 101.5K | $5M | +1.14% |
| Q2 2023 | 10.6K | $679,328 | +0.23% |
| Q1 2023 | 10.1K | $702,865 | +0.25% |
| Q4 2022 | 8.7K | $625,725 | +0.23% |
| Q3 2022 | 6.9K | $492,000 | +0.21% |
| Q2 2022 | 6.5K | $497,000 | +0.20% |
| Q1 2022 | 3.1K | $243,000 | +0.09% |
| Q2 2021 | 3.4K | $224,000 | +0.11% |
| Q1 2021 | 3.4K | $216,000 | +0.13% |
| Q4 2020 | 3.6K | $224,000 | +0.16% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ellsworth Advisors, LLC’s full portfolio or all institutional holders of BMY.